Search PIII
P3 Health Partners Inc.
Nasdaq, Nasdaq · CIK 1832511
Last close6.36
Daily change+0.09 (1.44%)
10 Years gain-98.69%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
PIII · STANDARD
SIC 8000 · Services-Health Services · Fiscal year end 1231
Fundamental
29.3Momentum
100.0Acceleration
100.0Confidence
84.0Annual Revenue7
Quarterly Revenue21
Annual CFO7
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth8.9 / 25
Quality17.6 / 25
Capital Efficiency0.0 / 20
Balance Sheet1.3 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 12.6938 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM-1.94%OK
Revenue CAGR 3Y11.61%OK
Gross Margin100%OK
Operating Margin-1.96%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-12.47%OK
Incremental Operating Margin 3Y361.04%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y3.13%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 FY Dec 31, 2025 | $1.46B | $1.46B | -$270.30M | -$91.24M | n/a | 100% | -18.53% | n/a | -219.96% | 3.27M |
| 2024 FY Dec 31, 2024 | $1.50B | $1.50B | -$320.66M | -$110.13M | -$110.13M | 100% | -21.37% | -7.34% | -140.67% | 2.94M |
| 2024 FY Dec 31, 2023 | $1.27B | $1.27B | -$167.93M | -$76.03M | -$77.86M | 100% | -13.26% | -6.15% | -89.38% | 294.59M |
| 2023 FY Dec 31, 2022 | $1.05B | $1.05B | -$1.56B | -$126.02M | -$128.25M | 100% | -148.73% | -12.22% | -683.04% | 41.58M |
| 2022 FY Dec 02, 2021 | $578.60M | $578.60M | -$129.06M | -$51.13M | -$54.42M | 100% | -22.31% | -9.41% | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.47B | sum latest 4 fiscal quarters Revenue | OK | 0001832511-26-000034, 0001832511-25-000025 |
| Revenue Growth TTM | -1.94% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001832511-26-000034, 0001832511-25-000025 |
| Revenue CAGR 3Y | 11.61% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001832511-26-000011 |
| Revenue CAGR 5Y | 24.33% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001832511-26-000011 |
| Gross Profit CAGR 3Y | 11.61% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001832511-26-000011 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001832511-26-000034, 0001832511-25-000025 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 100% | Gross Profit / Revenue | OK | 0001832511-26-000034, 0001832511-25-000025 |
| Operating Margin | -1.96% | Operating Income / Revenue | OK | 0001832511-26-000034, 0001832511-25-000025 |
| ROIC | -12.47% | NOPAT / Average Invested Capital | OK | 0001832511-26-000034, 0001832511-25-000025 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001832511-26-000034 |
| Current Ratio | 0.46x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.18x | (Cash + Short-term Investments) / Total Debt | OK | 0001832511-26-000034 |
| Revenue per Diluted Share | $438.37 | Revenue / Diluted Shares | OK | 0001832511-26-000034, 0001832511-25-000025 |